Drug Approval | June 26, 2024
USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
_256_384.jpg)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Subscribe To Our Newsletter & Stay Updated
